CWM, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
CWM, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25
+66.7%
1,205
+274.2%
0.00%
Q2 2023$15
+87.5%
322
+68.6%
0.00%
Q1 2023$8
+700.0%
191
+536.7%
0.00%
Q4 2022$1
-99.9%
300.0%0.00%
Q3 2022$1,0000.0%300.0%0.00%
Q2 2022$1,000
-50.0%
30
-52.4%
0.00%
Q1 2022$2,000
+100.0%
63
+350.0%
0.00%
Q4 2021$1,0000.0%140.0%0.00%
Q2 2021$1,0000.0%140.0%0.00%
Q1 2021$1,0000.0%140.0%0.00%
Q4 2020$1,0000.0%140.0%0.00%
Q3 2020$1,0000.0%140.0%0.00%
Q2 2020$1,0000.0%140.0%0.00%
Q1 2020$1,0000.0%140.0%0.00%
Q4 2019$1,0000.0%140.0%0.00%
Q3 2019$1,0000.0%140.0%0.00%
Q2 2019$1,0000.0%140.0%0.00%
Q1 2019$1,0000.0%14
+133.3%
0.00%
Q4 2018$1,0000.0%60.0%0.00%
Q3 2018$1,0000.0%60.0%0.00%
Q2 2018$1,0000.0%60.0%0.00%
Q1 2018$1,0000.0%60.0%0.00%
Q4 2017$1,00060.0%0.00%
Q3 2017$060.0%0.00%
Q2 2017$060.0%0.00%
Q1 2017$060.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders